Financials

  • Market Capitalization 288.86 M
  • Employee 122
  • Founded 2020
  • CEO N/A
  • Website www.invivyd.com
  • Headquarter Delaware, United States
  • FIGI BBG00W4ML039
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.81
Rapporto prezzo/fatturato
3.28

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3347
RNAC
Cartesian Therapeutics, Inc. - Common Stock
9.60 USD-3.71%-5.70%+21.67%+4.80%290.45 M USD
3349
TTRX
Turn Therapeutics Inc. - Common Stock
9.73 USD-1.12%+4.74%+12.49%-2.70%289.84 M USD
3361
FATE
Fate Therapeutics, Inc. - Common Stock
2.38 USD-2.06%0.00%-2.06%+128.85%285.17 M USD
3375
LCTX
Lineage Cell Therapeutics, Inc. Common Stock
1.11 USD-0.89%+0.91%+1.83%-35.35%280.73 M USD

Notizie